(Q70965524)
Statements
A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study (English)
J M Bennett
G H Lymann
P A Cassileth
J H Glick
scientific article published on 01 October 1984
No description defined